Webinar: Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents

Webinar
3:00 - 4:00 p.m. EST
Phone number: 1-650-479-3208
Access # 623 387 067
Password: Concussion

Join the webinar event on March 6, 2019 from 3:00 p.m. - 4:00 p.m. EST to discuss a new funding opportunity announcement: RFA-NS-19-022 on the Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW).

 (Application due date April 10, 2019)

• RFA-NS-19-022 - Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed)
  
  This Funding Opportunity Announcement (FOA) is aimed at discovering, characterizing the selectivity and sensitivity, and externally validating biological measures to be used for assessing, prognosing, and monitoring recovery of adolescents who either clinically present with or are at risk for developing prolonged/persistent concussive symptoms following exposure to repetitive head impacts and/or concussion.  Resultant biological measures should be incorporated into risk stratification algorithms to inform clinical care and patient stratification for future clinical trials.  A critical feature of this FOA includes the broad sharing of clinical, neuroimaging, physiological, and biospecimen data to further advance research in the area of persistent concussive symptoms in early and middle adolescent (EMA; ages 11-17 years old) populations.

Related Resources